KEGG   COMPOUND: C07897Help
Entry
C07897                      Compound                               

Name
Etanercept
Remark
Same as: D00742
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
     L04AB01 Etanercept
      D00742  Etanercept (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Immunological Agents
  Immune Suppressants
   Etanercept
    D00742  Etanercept (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D00742  Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Tumor necrosis factors
    TNF (TNFA, TNFSF2)
     D00742  Etanercept (USAN/INN) <JP/US>
    LTA (TNFB, TNFSF1)
     D00742  Etanercept (USAN/INN) <JP/US>
Drug classes of therapeutic agents [br08360.html]
 Antirheumatic and antigout agents
  D00742
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00742
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D00742
BRITE hierarchy
Other DBs
CAS: 185243-69-0
PubChem: 10099
NIKKAJI: J2.104.917D
LinkDB All DBs

» Japanese version

DBGET integrated database retrieval system